Activation of either adenosine A, receptors or GABA, receptors inhibits many excitatory synapses in the mammalian brain. However, the extent to which different mechanisms contribute to such synaptic modulation is unclear. We examined the manner in which activation of adenosine A, receptors and GABA, receptors modulates synaptic strength at the granule cell to Purkinje cell synapse in rat cerebellar slices. Optical determination of presynaptic calcium influx revealed that presynaptic calcium channels were modulated by 2-chloroadenosine (2CA) and baclofen, agonists of the adenosine A, receptor and the GABA, receptor, respectively. 2CA and baclofen differentially affected three classes of calcium channels without altering the shape of the presynaptic volley, suggesting that changes in presynaptic waveform do not contribute significantly to synaptic modulation.
Many excitatory synapses in the mammalian brain are inhibited by activation of adenosine A, receptors or GABA, receptors. Such inhibition may serve as a means of fine tuning synaptic strength, or as a general mechanism for synaptic depression during periods of high activity that lead to a build-up of extracellular adenosine or GABA (Silinsky et al., 1990; Isaacson et al., 1993) . Considering that synaptic strength can be altered in many ways, and that presynaptic terminals are small and inaccessible, it is not surprising that it has been difficult to determine the mechanisms responsible for such modulation of transmission in the mammalian CNS.
In the study of synaptic modulation by activation of A, and GABA, receptors, it is useful to consider ways in which synaptic strength can be changed. (1) The threshold for fiber activation can be modulated, leading to an alteration in stimulus-evoked synaptic currents (Sabatini and Regehr, 1995) . (2) A change in action potential waveform can affect the activation of voltage-gated calcium channels, thereby indirectly affecting the calcium signal available to trigger neurotransmitter release. Such a change in action potential waveform could arise in a number of ways, including activation of potassium channels (Gahwiler and Brown, 1985) . (3) Modulation of presynaptic calcium channels may contribute to synaptic modulation. Although modulation of somatic calcium currents has been observed widely (Anwyl, 1991) , there is relatively little direct evidence regarding the modulation of presynaptic calcium channels involved in transmitter release. (4) Modification of steady-state calcium levels in presynaptic termi-nals can affect synaptic strength (Zucker et al., 1991) . (5) Transmission can be modulated presynaptically, downstream of calcium influx. Changes in the frequency of miniature EPSCs (mEPSCs), which are caused by spontaneous fusion of single vesicles (Fatt and Katz, 1952) are thought to reflect such modulation (see Discussion). (6) Postsynaptic neurotransmitter sensitivity can be altered (Greengard et al., 1991) . This list of ways to modulate synaptic strength, although not exhaustive, is a useful starting point in the examination of synaptic modulation.
Many of these mechanisms have been implicated in the modulation of synaptic transmission by activation of the adenosine A, receptor and the GABA, receptor. Activation of either of these G-protein-coupled receptors modulates somatic calcium channels in many types of cells (Anwyl, 1991; Mintz and Bean, 1993; Umemiya and Berger, 1994) . At some synapses, inhibition of presynaptic calcium influx by adenosine or baclofen is thought to contribute to changes in synaptic strength (Yawo and Chuhma, 1993; Wu and Saggau, 1994, 1995) . In addition, activation of A, and GABA, receptors can decrease mEPSC frequency, implicating presynaptic changes that are downstream from calcium influx (Prince and Stevens, 1992; Scanziani et al., 1992) . Furthermore, baclofen, a selective GABA,-receptor agonist, and adenosine have both been shown to modulate potassium channels and affect the action potential waveform (Alford and Grillner, 1991; Greene and Haas, 1991) . It is apparent from these studies that the activation of A, receptors and GABA, receptors can have complex actions. However, the relative contribution of these mechanisms remains much debated.
Here we study the inhibition of synaptic transmission by 2-chloroadenosine (2CA), an A,-receptor agonist, and by baclofen at the granule cell to Purkinje cell synapse in the cerebellum. This synapse is well suited to these studies because synaptic currents can be voltage-clamped (Llano et al., 1991) and changes in presynaptic calcium influx produced by single stimuli can be measured optically using the fluorescence transients of low-affinity calcium indicators (Mintz et al., 1995; Regehr and Atluri, 1995) . We find that activation of the A, receptor affects transmission at this synapse almost exclusively by modulating calcium channels sensitive to o-agatoxin-IVA (o-Aga-IVA) and o-conotoxin-GVIA (CgTx). Baclofen also reduces synaptic strength by modulating these two types of calcium channels, but appears to have additional presynaptic effects downstream from calcium entry.
MATERIALS
AND METHODS Synaptic physiology. Transverse slices (250-300 pm thick) were cut from the cerebellar vermis of 9-to 14-d-old Sprague-Dawley rats. Slices were superperfused at l-2 ml/min with an external solution containing (in mM): 125 NaCI, 2.5 KCI, 2 CaCl,, 1 MgCl,, 26 NaHCO,, 1.25 NaH,PO,, and 25 glucose, bubbled with 95%0,/5% CO,. Bicuculline (20 pM) was added to the external solution to suppress inhibitory synaptic currents.
Whole-cell recordings of Purkinje cells were obtained as described previously (Regehr and Mintz, 1994 ) using 1.5-2.5 MR glass pipettes containing an internal solution of (in mM): 35 CsF, 100 CsCI, 10 EGTA, 10 K-HEPES, and 0.1 D600, adjusted to pH 7.2-7.3 with CsOH. The access resistance (<5 MR after series resistance compensation) and leak current were monitored continuously. Experiments were terminated and data rejected if either parameter varied significantly during recording.
Parallel fibers were activated by injecting a current pulse through a lo-15 pm saline-filled glass electrode placed in the molecular layer several hundred micrometers from the recording site. The stimulus intensity was adjusted to keep synaptic currents sufficiently small so that uncompensated series resistance voltage errors were <4 mV. The EPSC decay time course varied between 5 and 7.5 msec. The recording was allowed to stabilize for 15-20 min after break-in, and control EPSCs were recorded for -10 min before any pharmacological manipulation of synaptic transmission. At the end of the experiments, 100 pM cadmium was added, allowing us to record the stimulus artifact in isolation. The stimulus artifact was removed for clarity in Figures 1B and 2B .
2CA and baclofen (Research Biochemicals, Natick, MA) were prepared as stock solutions in distilled water (10 mM) and stored at -20°C. Dilutions to final concentrations were made just before recording. Peptide toxins were prepared as described previously (Mintz et al., 1995) . Currents were filtered at 1 kHz and digitized every 100 ksec. All experiments were done at 21-24°C. Averages are given as mean 2 SEM.
Fluorometric detection of calcium transients. Parallel fibers were labeled with a high-pressure stream of Furaptra-AM (also known as mag-Fura-2; Molecular Probes, Eugene, OR) or mag-Fura-as described previously (Regehr and Tank, 1991; Regehr and Atluri, 1995) . Fluorescence was measured with a photodiode, and the output was filtered at 500 Hz with a 4-pole Bessel filter (Warner, Hamden, CT) and digitally recorded with a 16-bit converter (Instrutech, Great Neck, NY) using PULSE CON-TROL software (Herrington and Bookman, 1994) . The AF/F ratio was calculated and used as a linear measure of presynaptic calcium influx as established previously (Regehr and Atluri, 1995) .
Monitoring resting calcium. Fura-was used to test for changes in resting calcium. Parallel fibers were labeled for 10 min with a highpressure stream of Fura-AM. After allowing 2 hr for the dye to equilibrate, resting calcium levels were determined using the ratio method with 350 and 380 nm illumination. A Sutter filter wheel was used to alternate between excitation filters. Fluorescence transients produced by single stimuli were recorded in parallel to ensure that the effect on calcium influx by 2CA and baclofen had reached steady state. Measuring presynaptic action potential waveform and fiber threshold. Field potentials were recorded by placing a saline-filled electrode (2 MR resistance) between 400 and 800 pm away from the stimulus electrode in the molecular layer. Parallel fiber stimulation produced a stereotyped waveform (Eccles et al., 1967) that corresponded to the current flow during a propagating action potential. The amplitude of the presynaptic volley was defined as the peak-to-peak magnitude. Bicuculline (20 pM) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 2 PM) were added to the extracellular solution to minimize contamination by postsynaptic currents.
Stimulus threshold effects. Changes in fiber stimulus threshold (Fig. 3 ) altered the curve relating EPSC amplitude and calcium influx (Fig. 4) . To assess the magnitude of this effect, we divided the EPSC and calcium influx values by the relative number of fibers stimulated. For 2CA the Because of the small size of these effects, Figure 4 was not corrected for changes in parallel fiber threshold.
Measurement of mEPSCs. Purkinje cell spontaneous EPSCs were recorded in whole-cell configuration using 2-2.5 Ma glass pipettes in the presence of 0.2-0.5 pM tetrodotoxin (TTX) to block evoked synaptic transmission and 20 pM bicuculline to suppress spontaneous IPSCs. Cadmium (100 pM) did not affect the amplitude or frequency of mEPSCs (n = 3). We tested a number of recording conditions and found that an external solution without cadmium combined with the following internal solution-facilitated stable recordings of mEPSCs (in mM): 88 Cs,SO,, 10 EGTA, 4 MgSO,, 4 CaCI,, 1.5 MgCI,, 4 Na,-ATP, 0.4 Na,-GTP, 0.1 D600, adjusted to pH 7.3 with CsOH.
Data were collected in 20 set epochs, filtered at 500 Hz with an g-pole Bessel filter (Frequency Devices, Haverhill, MA), and digitized every 400 psec. The access resistance was <lo MQ and no series resistance compensation was used to minimize noise contributions from the voltageclamp circuit. The root-mean-square current for a typical experiment was 5 pA. Some data were recorded using sagittal slices, but there was no apparent difference between sagittal and transverse slices with regard to mEPSC frequency or amplitude. Events were counted and analyzed off-line using IGOR PRO software (WaveMetrics, Lake Oswego, OR). The criteria for inclusion were an 8-10 pA amplitude threshold, a rise time (lo-90%) between 1 and 5 msec, and a half-decay time between 4 and 15 msec. Overlapping events were rejected. The rejected events typically accounted for <20% of the total number of detected events. Amplitude histograms were binned with 2 pA intervals. To detect changes in amplitude, the amplitude histograms were integrated and normalized. As cumulative distributions, histograms were compared using the Kolmogorov-Smirnov test for significance. For the data shown here, statistical significance was assumed when p = 0.05.
RESULTS
The modulation of presynaptic calcium influx and synaptic strength by 2CA and baclofen Experiments were performed to determine whether alterations of presynaptic calcium influx contribute to inhibition of synaptic transmission by baclofen and 2CA. The relationship between synaptic strength and presynaptic calcium entry was determined by recording synaptic currents with whole-cell voltage clamp and by detecting changes in calcium influx optically, with the calciumsensitive fluorophore Furaptra (Raju et al., 1989; Regehr and Atluri, 1995) or mag-Fura-5. By using these low-affinity indicators (K,, for calcium of -49 and 23 PM for Furaptra and mag-Fura-5, respectively) (Delbono and Stefani, 1993) we avoided distortion of fluorescence signals, as occurred for high-affinity dyes such as Fura-under similar experimental conditions (Regehr and Atluri, 1995). Thus, as described previously, we were able to use AF/F signals produced by single stimuli to accurately measure changes in calcium entering the presynaptic terminals during an action potential (Mintz et al., 1995; Regehr and Atluri, 1995) .
2CA reduced calcium influx and synaptic strength in a dosedependent manner (Fig. 1) . As shown for a representative experiment, 2CA reversibly inhibited presynaptic calcium entry (Fig.  lA) . The peak synaptic current was also reduced by 2CA, as shown for the experiment of Figure 1B with ECs,, = 1.4 PM and A, = 39.5%, and peak EPSCs were fit to this function raised to the nth power (n = 4.3; Fig. 2C ).
The effect of baclofen and 2CA on resting calcium levels Small changes in resting calcium levels could affect synaptic transmission. We measured the effects of baclofen and 2CA on resting calcium levels using ratiometric measurements of the indicator Fura-and found that 30 PM baclofen and 30 PM 2CA did not affect resting calcium levels (data not shown). The effect of adenosine and baclofen on the action potential waveform and the number of fibers stimulated
We tested for possible effects of 2CA and baclofen on the number of parallel fibers activated by extracellular stimulation. The presynaptic volley, which is caused by extracellular current how associated with action potentials propagating in parallel fibers, serves as a sensitive measure of the number of fibers activated. 3C). Baclofen had a small but more pronounced effect on the rather than indirectly by altering the presynaptic waveform (but number of fibers stimulated (Fig. 30) .
see Discussion). The reduction in the number of parallel fibers activated will contribute to the effect of baclofen and 2CA on calcium influx and synaptic strength. However, correcting the data in Figures 1 and 2 for changes in fiber activation does not change significantly the relationship between calcium influx and release for either 2CA or baclofen (see Materials and Methods).
The relationship between calcium influx and synaptic strength for activation of the A, receptor and the GABA, receptor Measurement of the presynaptic volley waveform facilitates detection of broadening or narrowing of the presynaptic action potential, which could alter the activation of voltage-gated calcium channels. As shown in Figure 3 , A and B (insets), baclofen and 2CA affect the amplitude but not the shape of the presynaptic volley. This suggests that the reduction of calcium influx described in Figures 1 and 2 arises directly by modulating calcium channels, It appears that EPSC amplitude is more steeply dependent on calcium influx for baclofen (n = 4.3) than for 2CA (n = 2.35). Figure 4A shows the relationship between EPSC amplitude and calcium influx for various concentrations of these modulators. The curves in Figure 4A are power-law fits from Figures 1C and 2C .
It is clear that both 2CA and baclofen inhibit synaptic strength, and that a reduction in presynaptic calcium influx contributes to this inhibition. Is this reduction in calcium influx the sole mechanism responsible for the decrease in synaptic strength? To ad- dress this question, we compared the relationship between calcium influx and release for these neuromodulators with that observed when calcium entry is manipulated directly (Fig. 4B) , as described in a previous study (Mintz et al., 1995) . In that study, we found that transmission is mediated by three pharmacologically distinct components of calcium influx: one sensitive to the calcium channel toxin (w-Aga-IVA) (Mintz et al., 1992) another to CgTx (Williams et al., 1992; Fujita et al., 1993) , and a component insensitive to both of these toxins. We also determined the relationship between calcium intlux and synaptic strength when calcium influx was manipulated by changing external calcium levels, by adding the calcium channel blocker cadmium, and by adding o-Aga-IVA and/or CgTx. These studies served as a standard for relating calcium influx and synaptic strength when flux through calcium channels is altered. The light shaded region in Figure 4B corresponds to the relationship between calcium and release when calcium entry is reduced by lowering external calcium, by adding external cadmium, and by adding the calcium channel antagonist CgTx. The close similarity between these conditions and the 2CA data suggests that 2CA inhibits synaptic strength primarily by reducing presynaptic calcium influx. The power-law dependence is much steeper for baclofen than for 2CA. Below we will examine several mechanisms that could account for this difference.
Classification of presynaptic calcium channels targeted by 2CA and baclofen Calcium channels may be coupled differentially to release at the parallel fiber to Purkinje cell synapse (Mintz et al., 1995) , so it is particularly important to determine the selectivity of 2CA and baclofen for the modulation of various types of presynaptic calcium channels. As shown in Figure 4B , calcium channels blocked by w-Aga-IVA (shaded rectangle) appear to be more effective at triggering release than channels blocked by CgTx.
As shown in Figure 5A , after addition of maximal 2CA, CgTx and w-Aga-IVA further reduced calcium influx. We have shown previously that CgTx and w-Aga-IVA block nonoverlapping components of calcium influx in parallel fibers and that they do not affect the amplitude or waveform of evoked presynaptic volleys (Mintz et al., 1995) . Figure 5B summarizes experiments similar to that of Figure 5A and shows the fraction of calcium influx remaining in the presence 2CA. The toxin sensitivity of the fraction blocked by 2CA and the reduction of each of the components by 2CA are calculated from the fraction of calcium influx that remains in the presence of 2CA, and the calcium influx in control conditions (27% CgTx-sensitive, 50% o-Aga-IVA-sensitive, and 23% toxin-insensitive) (Mintz et al., 1995) . 2CA preferentially targets the CgTx-sensitive component, blocks the o-Aga-IVAsensitive fraction to a large extent, and negligibly affects the toxin-insensitive component.
Similar experiments were performed for baclofen (Fig. 6 ). As indicated in Figure 6B , baclofen also inhibited both o-Aga-IVAsensitive and CgTx-sensitive components with little or no effect on the toxin-insensitive fraction. However, baclofen was slightly less effective at reducing entry through the CgTx-sensitive channel (74 vs 82% reduction for w-Aga-IVA), whereas 2CA was much more effective at reducing entry though CgTx-sensitive channels than through o-Aga-IVA-sensitive channels (84 and 42% reduction, respectively). Such differential modulation of calcium channel components, combined with the more effective coupling of o-Aga-IVA-sensitive calcium channels to release, could contribute to the differences in the relationship between calcium influx and release for baclofen and 2CA (see Discussion). These results demonstrate both specificity and overlap in the inhibition of presynaptic calcium channels, similar in many ways to descriptions of modulation of somatic calcium channels (Anwyl, 1991; Mintz and Bean, 1993; Umemiya and Berger, 1994) .
Effects of 2CA and baclofen on spontaneous release of neurotransmitter and postsynaptic responsiveness To test for presynaptic changes in synaptic transmission that are calcium-independent and to test for changes in postsynaptic glutamate responsiveness, we recorded mEPSCs in the presence of TTX and bicuculline.
We began by pharmacologically characterizing the mEPSCs. Figure 7A evoked parallel fiber EPSCs (Konnerth et al., 1990; Perkel et al., 1990) reversibly eliminated the mEPSCs (Fig. 7A) . The time course of the mEPSCs was similar to that of evoked parallel fiber EPSCs (Fig. 7B, inset) , as described previously (Barbour, 1993) . The amplitude histogram in Figure 7B shows the distribution of the mEPSC amplitudes recorded over -300 sec. As shown in Figure 7 , C and D, we were able to detect changes in mEPSC amplitude. Changing the holding potential from -70 to -50 mV affected the amplitude distribution of the mEPSCs. The apparent frequency of mEPSCs also decreased because of loss of small events in the background noise. A normalized cumulative amplitude histogram was generated to determine whether the amplitude distribution was affected (Fig. 70, inset) . By comparing data taken at -50 and -70 mV, a statistically significant (p = 0.001 by the Kolmogorv-Smirnov test) reduction in mEPSC amplitude was detected. This comparison can be used to detect amplitude changes even when there is an apparent decrease in mEPSC frequency.
As shown in Figure 8 , 2CA did not affect the frequency or amplitude of mEPSCs. No significant decrease was observed in 5 pM 2CA (5.5 -C 3.4%; 12 = 3). The amplitude distributions for mEPSCs in the presence and absence of 2CA were virtually identical (Fig. 8C ). There was no significant effect 0, = 1.00) on mEPSC amplitude, as shown in Figure SC (inset) . Changing the holding potential from -70 to -50 mV in the same experiment caused a detectable change in the normalized cumulative amplitude histogram (p = 0.03; data not shown).
In contrast, baclofen substantially reduced the mEPSC frequency (39.8 ? 2.9%; n = 4) as shown in Figure 9 . The amplitude distribution for this experiment is shown in Figure 9C . The normalized cumulative amplitude distribution showed no significant change (p = 0.86) in the presence of 5 PM baclofen. Changing the holding potential from -70 to -50 mV caused a significant change in the cumulative amplitude distribution during the same experiment (p = 0.05; data not shown). This suggests that a majority of the mEPSC frequency decrease in the presence of baclofen cannot be accounted for by a decrease in mEPSC amplitude. Thus, baclofen decreases mEPSC frequency without substantially affecting postsynaptic glutamate sensitivity.
DISCUSSION
We used several approaches to study synaptic inhibition at the parallel fiber to Purkinje cell synapse by activation of GABA, receptors and adenosine A, receptors. Our findings lend support to the view that modulation of presynaptic calcium channels is an important means of controlling synaptic strength. We also find that synaptic modifications can arise from multiple mechanisms acting in concert. The relative contributions of a number of mechanisms to synaptic inhibition are discussed in detail below. Parallel fiber excitability In our experiments, parallel fibers were activated with an extracellular electrode, as has been the case in most studies of synaptic transmission in the CNS. A change in fiber excitability would contribute to changes in stimulus-evoked synaptic currents by affecting the number of fibers activated (Sabatini and Regehr, 1995) . Because baclofen and 2CA are known to modulate a variety of channel types, including potassium channels (Gahwiler and Brown, 1985; Proctor and Dunwiddie, 1987; Greene and Haas, 1991; Thompson and Gahwiler, 1992) , these neuromodulators may affect fiber excitability.
We found that 2CA had only minor effects on the number of fibers excited, in accord with previous studies in the hippocampus (Dunwiddie, 1984) . Baclofen reduced the number of excited fibers to a slightly larger extent. The reduction of the Dittman and Regehr . Mechanisms of Presynaptic Inhibition number of fibers stimulated was sufficiently small that it did not greatly affect the relationship between calcium influx and EPSC amplitude.
Alteration
of presynaptic waveform Calcium channel activation can be extremely sensitive to spike width (Augustine, 1990) and spike broadening contributes to modulation of some synapses (Klein and Kandel, 1980; Alford and Grillner, 1991) . We therefore considered the possibility that changes in presynaptic action potential waveform contribute to synaptic modulation by 2CA and baclofen. These modulators did not affect the shape of the presynaptic volley, which is sensitive to small waveform changes produced by low concentrations of tetraethylammonium (B. Sabatini and W. Regehr, unpublished observations). It is difficult, however, to exclude subtle waveform changes in the presynaptic terminals that could not be detected with an extracellular electrode. We also found that the various components of calcium influx were affected to very different degrees. This suggests that the presynaptic waveform is unchanged, because such an alteration would affect influx through all types of calcium channels similarly (unless they differed dramatically in their activation properties) (McCobb and Beam, 1991) . Taken together, the two lines of evidence described here suggest that changes in presynaptic waveform do not contribute significantly to synaptic modulation by 2CA and baclofen. More sensitive measures of the waveform in presynaptic terminals, and determination of the activation kinetics of the calcium channel components, will clarify further the participation of presynaptic waveform changes in synaptic modulation at this synapse. 1994). It appears that even modest increases in calcium can enhance the probability of release by acting at a high-affinity calcium-binding site distinct from the site involved in triggering vesicle fusion. We tested the possibility that activation of the A, receptor and the GABA, receptor might influence synaptic strength by altering steady-state calcium levels in presynaptic boutons. This was not the case, because ratiometric imaging of Fura-levels showed that 2CA and baclofen had no effect on resting calcium levels.
Postsynaptic effects Postsynaptic changes did not contribute to synaptic inhibition by baclofen and 2CA. Synaptic currents were voltage-clamped under conditions in which potassium channels and calcium channels in the Purkinje cell did not affect the synaptic currents (see Materials and Methods). This still leaves open the possibility that a decrease in postsynaptic sensitivity to glutamate (Greengard et al., 1991 ) could contribute to synaptic inhibition. By comparing amplitude distribution histograms for mEPSCs in Purkinje cells, we found no significant changes in glutamate sensitivity in the presence of baclofen or 2CA. This observation is consistent with similar experiments performed in the hippocampus (Prince and Stevens, 1992; Scanziani et al., 1992) .
Modulation
of presynaptic calcium channels There has been a great deal of debate about the relative contribution of calcium channel modulation to synaptic modulation in the CNS. By quantitating changes in presynaptic calcium influx with calcium indicators, we have shown that presynaptic calcium influx is reduced by 2CA and baclofen. These findings are in agreement with previous results that implicate calcium channel modulation in altering synaptic strength at other synapses (Scholz and Miller, 1991; Yawo and Chuhma, 1993; Umemiya and Berger, 1994; Wu and Saggau, 1994, 1995) .
By detecting changes in calcium influx with low-affinity cal- we were able to overcome difficulties that obtained in the presence of 2CA was remarkably similar to that prevented accurate quantification of changes in calcium influx obtained when external calcium was lowered, or when the in previous studies. This enabled us to evaluate the extent to calcium channel blockers cadmium or CgTx were added. This which the observed reduction in presynaptic calcium influx suggested that the observed changes in calcium influx were could account for the changes in synaptic strength. As shown in sufficient to account entirely for the inhibition of synaptic Figure 4 , the relationship between calcium influx and release transmission by 2CA. Reduction of presynaptic calcium entry accounts for a large part of the inhibition of synaptic transmission by baclofen (Fig. 4) . However, the relationship between calcium entry and release was much steeper for baclofen than for 2CA. The more pronounced effect of baclofen on the o-Aga-IVA-sensitive channel, which may be more effectively coupled to release, appears to contribute to differences between baclofen and 2CA in their calcium-release relationship (as discussed below, this is not the only mechanism).
Mechanisms downstream from calcium influx
Because baclofen and 2CA profoundly decreased mEPSC frequency in the hippocampus (Scanziani et al., 1992) it has been proposed that inhibition of evoked synaptic currents are largely independent of changes in presynaptic calcium influx. Others have suggested that adenosine decreases either the probability of release or the number of release sites at hippocampal synapses (Prince and Stevens, 1992; Chavez-Noriega and Stevens, 1994) . We found that 2CA had no measurable effects on spontaneous release at concentrations that potently reduced synaptic strength. This supports our conclusion that at the granule cell to Purkinje cell synapse, activation of the A, receptor decreases synaptic strength by modulating presynaptic calcium channels and not via other presynaptic mechanisms.
In contrast, baclofen decreased the average mEPSC frequency by -4O%, suggesting that activation of GABA, receptors inhibits a process involved in transmitter release after calcium influx. We estimate that baclofen reduces synaptic strength primarily through calcium channel modulation (70-90%) with presynaptic mechanisms downstream from calcium influx accounting for the remaining lo-30%. These estimates are based on the calcium influx and synaptic strength curves of Figure 4 .
Application of this approach to other synapses
The approach described here promises to be applicable to the study of many forms of synaptic modulation in the mammalian brain, and has great potential for resolving disputes over the relative contribution of different mechanisms to synaptic modulation. One important aspect of our approach is the ability to accurately quantify changes in calcium influx by using lowaffinity calcium indicators. Also, by studying the same preparation with multiple techniques, we can estimate the contribution of many mechanisms to synaptic modulation.
